Executive/Senior Director, Medical Affairs

Oric Pharmaceuticals•South San Francisco, CA

17d•$300,000 - $340,000•Onsite

About The Position

ORIC Pharmaceuticals is seeking a Senior/Executive Director, Medical Affairs, as an initial member of the Global Medical Affairs (GMA) team based in ORIC's South San Francisco office. Reporting to the Head of Medical Affairs, this individual will be responsible for developing and executing the GMA strategy and tactical plans with a focus on launch readiness and life cycle management for therapies across prostate cancer, non-small cell lung cancer (NSCLC), and potentially other tumor types. The successful candidate will have a proven track record of developing and driving medical strategy for multiple assets with a focus on effectively analyzing and communicating key scientific data through publications, medical information, medical communications, congress activities as well as gathering insights through advisory boards, advocacy, and Key Opinion Leader (KOL) relationships. The candidate must work collaboratively with cross-functional counterparts in Clinical Development and Operations, Regulatory, Research, Finance, Legal, and Commercial as well as other ORIC functional groups to design and implement a medical strategy for rinzimetostat in prostate cancer and enozertinib in NSCLC.The ideal candidate will have background experience in biotech/biopharma, during both pre-launch and post-launch product phases, is an experienced and collaborative leader, highly effective communicator, entrepreneurial, solutions-oriented, proactive, and scientifically driven.

Requirements

An advanced medical/scientific degree (MD, PhD, NP/PA, or PharmD) with a strong background in oncology.
10+ years of experience in medical affairs, biotech and/or pharmaceutical industry with at least 5 years in a senior leadership role.
Must have a strong scientific background in oncology with deep understanding of biomarker-driven disease and ability to effectively analyze, synthesize, and communicate complex scientific information.
Strong networking skills with deep existing relationships and network with oncology healthcare professionals including global key opinion leaders.
Previous overall responsibility and accountability for medical affairs activities, including budget management for more than one compound (pipeline and marketed).
Hands-on experience executing direct US and global activities of various functions within medical affairs (training, medical communications, medical information, EAP, evidence generation, publications, etc.).
Proven track record of clinical trial support including protocol development/review, site selection support, enrollment support, and data analysis.
Extensive experience in product launches including integrated brand plan ideation, regulatory submissions, label development, patient access and reimbursement.
Exceptional verbal, written, and presentation skills with the ability to effectively communicate complex scientific data to diverse audiences.
Ability to manage multiple priorities at one time with little direction and drive results in a fast-paced and dynamic environment.
Ability to travel to South San Francisco and San Diego headquarters and to attend scientific congresses, trial related meetings, and key stakeholder meetings (domestic and some international) - up to 50% travel.
Manage and adhere to ORIC policies, ensuring compliance with corporate rules and government regulations.

Responsibilities

Build and lead key Global Medical Affairs (GMA) capabilities in areas such as medical communications, operations, field medical, and a robust independent scientific research assessment process.
Facilitate the development and execution of the multi-year US and global medical strategy and plan for rinzimetostat and enozertinib, including activities related to scientific engagement and communication, internal education, and patient advocacy.
Lead integrated evidence generation planning in prostate, NSCLC and other disease areas of interest, including development/refinement of a publication strategy/plan, an evidence/RWD generation plan, and tactical plan as part of the overall GMA plan.
Provide medical leadership in scientific engagement activities with key stakeholders through organizing and leading advisory boards, investigator interactions, congress activities, educational presentations and peer-to-peer discussions with the goal of exchanging and communicating scientific insights to internal teams to drive strategy.
Lead the operations and oversight of medical affairs activities in key therapeutic areas while working cross-functionally with multiple functional leaders to support pre-launch/launch activities, and provide regular updates and support to management.
Develop and execute a strategic plan for key opinion leader outreach and insights generation by proactively establishing and maintaining strong relationships with thought leaders, academic institutions, advocacy and medical societies in the field of oncology.
Work closely with the Clinical, CRO, and future MSL teams to provide recruitment, scientific, and engagement support to facilitate clinical trial enrolment and timelines.
Lead Patient Advocacy strategy and planning to incorporate the patient voice and define external medical education strategies for independent grants, respectively.
Support competitive intelligence team activities through landscape assessments, development of patient journey, and congress insights.
Provide medical support for scientific symposia and medical congresses and collaborate across functions to develop, review, and align on key scientific communication points, educational tactics, and medical information response documents within legal and compliance guidelines.
Support the review and approval of abstracts, manuscripts, posters, presentations, and other documents as well as internal stakeholder medical education activities
Provide medical strategy leadership for Expanded Access Programs (EAP) and Investigator-Initiated Studies (IIS).
Manage operating budget, systems, processes, and future personnel efficiently to maximize ORIC resources.